Transdermal fentanyl patches in small animals

Journal of the American Animal Hospital Association

Volumn 40, Issue 6, 2004, Pages 468-478

  Hofmeister, Erik H ^a   Egger, Christine M ^b  

^a UNIVERSITY OF GEORGIA   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; BUTORPHANOL; FENTANYL; HYDROMORPHONE; MORPHINE;

ANOREXIA; BRADYCARDIA; CAT DISEASE; DEATH; DISEASE SEVERITY; DOG DISEASE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG COST; DRUG DELIVERY SYSTEM; DRUG DOSE REGIMEN; DYSPHORIA; EUPHORIA; HYPERCAPNIA; HYPERTHERMIA; HYPOTENSION; NONHUMAN; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; REVIEW; SEDATION; SKIN MANIFESTATION; TRANSDERMAL PATCH;

ANIMALIA; CANIS FAMILIARIS;

EID: 13844291229     PISSN: 15473317     EISSN: 15473317     Source Type: Journal    
DOI: 10.5326/0400468     Document Type: Review

References (50)

1. Krahwinkel DJ Jr, Sawyer DC, Eyster GE, et al. Cardiopulmonary effects of fentanyl-droperidol, nitrous oxide, and atropine sulfate in dogs. Am J Vet Res 1975;36:1211-1219.
2. Mather LE. Clinical pharmacokinetics of fentanyl and its newer derivatives. Clin Pharmacokinet 1983;8:422-446.
3. Southam MA. Transdermal fentanyl therapy: system design, pharmacokinetics and efficacy. Anti-Cancer Drugs 1995;6(Suppl 3):29-34.
4. Scherk-Nixon MA. A study of the use of a transdermal fentanyl patch in cats. J Am Anim Hosp Assoc 1996;32:19-24.
5. Schultheiss PJ, Morse BC, Baker WH. Evaluation of a transdermal fentanyl system in the dog. Contemp Top Lab Anim Sci 1995;54:75-81.
6. Kyles AE, Papich M, Hardie EM. Disposition of transdermally administered fentanyl in dogs. Am J Vet Res 1996;57:715-719.
7. Egger CM, Duke T, Archer J, et al. Comparison of plasma fentanyl concentrations by using three transdermal fentanyl patch sizes in dogs. Vet Surg 1998;27:156-166.
8. Kyles AE, Hardie EM, Hansen BD, et al. Comparison of transdermal fentanyl and intramuscular oxymorphone on post-operative behaviour after ovariohysterectomy in dogs. Res Vet Sci 1998;65:245-251.
9. Robinson TM, Kruse-Elliott KT, Markel MD, et al. A comparison of transdermal fentanyl versus epidural morphine for analgesia in dogs undergoing major orthopedic surgery. J Am Anim Hosp Assoc 1999;35:95-100.
10. Lee DD, Papich MG, Hardie EM. Comparison of pharmacokinetics of fentanyl after intravenous and transdermal administration in cats. Am J Vet Res 2000;61:672-677.
11. Franks JN, Boothe HW, Taylor L, et al. Evaluation of transdermal fentanyl patches for analgesia in cats undergoing onychectomy. J Am Vet Med Assoc 2000;217:1013-1020.
12. Glerum LE, Egger CM, Allen SW, et al. Analgesic effect of the transdermal fentanyl patch during and after feline ovariohysterectomy. Vet Surg 2001;30:351-358.
13. Gellasch KL, Kruse-Elliott KT, Osmond CS, et al. Comparison of transdermal administration of fentanyl versus intramuscular administration of butorphanol for analgesia after onychectomy in cats. J Am Vet Med Assoc 2002;220:1020-1024.
14. Welch JA, Wohl JS, Wright JC. Evaluation of postoperative respiratory function by serial blood gas analysis in dogs treated with transdermal fentanyl. J Vet Emerg Crit Care 2002;12:81-87.
15. Egger CM, Glerum LE, Allen SW, et al. Plasma fentanyl concentrations in awake cats and cats undergoing anesthesia and ovariohysterectomy using transdermal administration. Vet Anaesth Analg 2003;30:229-236.
16. Davidson CD, Pettifer GR, Henry JD. Plasma fentanyl concentrations and analgesic effects during full or partial exposure to transdermal fentanyl patches in cats. J Am Vet Med Assoc 2004;224:700-704.
17. Pettifer GR, Hosgood G. The effect of inhalant anesthetic and body temperature on peri-anesthetic serum concentrations of transdermally administered fentanyl in dogs. Vet Anaesth Analg 2004;31:109-120.
18. Pettifer GR, Hosgood G. The effect of rectal temperature on perianesthetic serum concentrations of transdermally administered fentanyl in cats anesthetized with isoflurane. Am J Vet Res 2003;64:1557-1561.
19. Greenhalgh T. How to read a paper: papers that summarise other papers (systematic reviews and meta-analyses). Br Med J 1997;315:672-675.
20. Chalmers I, Altman DG, eds. Systematic Reviews. London: BMJ Publishing Group, 1995.
21. Stoelting RK. Pharmacology and Physiology in Anesthetic Practice. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 1999.
22. Pascoe PJ. Opioid analgesics. Vet Clin North Am Small Anim Pract 2000;30:757-772.
23. Terenius L. Contribution of 'receptor' affinity to analgesic potency. J Pharm Pharmacol 1974;26:146-148.
24. Streisand JB, Varvel JR, Stanski DR, et al. Absorption and bioavailability of oral transmucosal fentanyl citrate. Anesthesiology 1991;75:223-229.
25. Plumb DC. Veterinary Drug Handbook. 3rd ed. Ames: Iowa State Univ Press, 1999.
26. Fung DL, Eisele JH. Fentanyl pharmacokinetics in awake volunteers. J Clin Pharmacol 1980;20:652-658.
27. Hengstman JH, Stoeckel H, Schuttler J. Infusion model for fentanyl based on pharmacokinetic analysis. Br J Anaesth 1980;52:1021-1025.
28. Hess R, Stibler G, Herz A. Pharmacokinetics of fentanyl in man and the rabbit. Europ J Clin Pharmacol 1972;4:137-141.
29. Bailey PL, Port JD, McJames S, et al. Is fentanyl an anesthetic in the dog? Anesth Analg 1987;66:542-548.
30. Hellyer PW, Mama KR, Shafford HL, et al. Effects of diazepam and flumazenil on minimum alveolar concentrations for dogs anesthetized with isoflurane or a combination of isoflurane and fentanyl. Am J Vet Res 2001;62:555-560.
31. Hug CC, Murphy MR. Fentanyl disposition in cerebrospinal fluid and plasma and its relationship to ventilatory depression in the dog. Anesthesiology 1979;50:342-349.
32. Marquardt KA, Tharratt RS, Musallam NA. Fentanyl remaining in a transdermal system following three days of continuous use. Ann Pharmacother 1995;29:969-971.
33. Flannagan LM, Butts JD, Anderson WH. Fentanyl patches left on dead bodies: potential source of drug for abusers. J Forensic Sci 1996;41:320-321.
34. Yerasi AB, Butts JD, Butts JD. Disposal of used fentanyl patches. Am J Health-Syst Pharm 1997;54:85-86.
35. Riviere JE, Papich MG. Potential and problems of developing transdermal patches for veterinary applications. Adv Drug Dev Res 2001;50:175-203.
36. Roy SD, Flynn GL. Solubility and related physicochemical properties of narcotic analgesics. Pharm Res 1988;5:580-586.
37. Chang SK, Riviere JE. Effect of humidity and occlusion on the percutaneous absorption of parathion in vitro. Pharm Res 1993;10:152-155.
38. Riviere JE, Sage BS, Williams PL. The effects of vasoactive drugs on transdermal lidocaine iontophoresis. J Pharm Sci 1991;80:615-620.
39. Gupta SK, Southam M, Gale R, et al. System functionality and physicochemical model of fentanyl transdermal system. J Pain Symptom Manage 1992;7 (Suppl):S17-26.
40. Hwang SS, Nichols KC, Southam M. Transdermal permeation: physiological and physicochemical aspects. In: Lehmann KA, Zech D, eds. Transdermal Fentanyl: A New Approach to Prolonged Pain Control. 1st ed. Berlin: Springer-Verlag, 1991:1-17.
41. Rose PG, Macfee MS, Boswell MV. Fentanyl transdermal system overdose secondary to cutaneous hyperthermia. Anesth Analg 1993;77:390-391.
42. Klockgether-Radke A, Hildebrandt J. Opioid intoxication. Inappropriate administration of transdermal fentanyl. Anaesthesist 1997;46:428-429.
43. Michiels M, Hendriks R, Heykants J. A sensitive radioimmunoassay for fentanyl. Plasma level in dogs and man. Eur J Clin Pharmacol 1977;12:153-158.
44. Hardie EM, Hyles AE. Pain management in the small animal patient. In: Bojrab MJ, ed. Current Techniques in Small Animal Surgery. 4th ed. Baltimore: Williams & Williams, 1998:3-17.
45. Broome IJ, Wright BM, Bower S, et al. Postoperative analgesia with transdermal fentanyl following lower abdominal surgery. Anaesthesia 1995;50:300-303.
46. Plezia PM, Kramer TH, Linford J, et al. Transdermal fentanyl: pharmacokinetics and preliminary clinical evaluation. Pharmacotherapy 1989;9:2-9.
47. Lemke KA, Tranquilli WJ, Thurmon JC, et al. Ability of flumazenil, butorphanol, and naloxone to reverse the anesthetic effects of oxymorphone-diazepam in dogs. J Am Vet Med Assoc 1996;209:776-779.
48. Schuh KJ, Walsh SL, Stitzer ML. Onset, magnitude and duration of opioid blockade produced by buprenorphine and naltrexone in humans. Psychopharmacology (Berl) 1999;145:162-174.
49. Dyson DH, Doherty T, Anderson GI, et al. Reversal of oxymorphone sedation by naloxone, nalmefene, and butorphanol. Vet Surg 1990;19:398-403.
50. Thurman JC, Tranquilli WJ, Benson GJ. Lumb & Jones' Veterinary Anesthesia. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 1996.